Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this study was to evaluate the diagnostic yield for lung complication after allo-HSCT by multiple parameter system through BAL.
一) Adult patients with hematology disease under allo-HSCT at any phase of treatment are enrolled according to the following criteria:
二) The BALF samples were tested using such methods
三) Pathogenic spectrum analysis and Targeted etiological therapy
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| BAL group | Adult patients with hematology disease under allo-HSCT at any phase of treatment are enrolled according to the following criteria:
|
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Bronchoscopic Alveolar Lavage | Diagnostic Test | The diagnostic yield of different diagnostic methods for lung infection and non-infectious diseases under allo-HSCT patients.
|
| Measure | Description | Time Frame |
|---|---|---|
| overall response rate | Efficiency of treatment for pulmonary complications after allo-HSCT | 100 days after BAL |
| Measure | Description | Time Frame |
|---|---|---|
| microbiology diagnostic yields | Comparing the pathogenic detection rate by BALF with non-invasive detection method | 100 days after BAL |
| all-cause mortality and attributable mortality of pulmonary complications |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
High morbidity and mortality in patient receiving hematopoietic Stem Cell Transplantation (HSCT) are resulted from lung complications. Diagnosis of the etiology affects the choice of treatment. The bronchoalveolar lavage (BAL) analysis is safe and widely accepted, which provide valuable information for pathogen identification in pulmonary infections diagnosis.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| xianmin song, M.D. | Contact | 86-21-37798987 | shongxm@139.com | |
| su li | Contact | 86-21-37798987 | lisuabcd@126.com |
| Name | Affiliation | Role |
|---|---|---|
| xianmin song, M.D. | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Principal Investigator |
Not provided
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 37541984 | Derived | Shen Z, Wang Y, Bao A, Yang J, Sun X, Cai Y, Wan L, Huang C, Xu X, Niu J, Xia X, Shen C, Wei Y, Qiu H, Zhou K, Zhang M, Tong Y, Song X. Metagenomic Next-Generation Sequencing for Pathogens in Bronchoalveolar Lavage Fluid Improves the Survival of Patients with Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation. Infect Dis Ther. 2023 Aug;12(8):2103-2115. doi: 10.1007/s40121-023-00850-w. Epub 2023 Aug 4. |
Not provided
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | Oct 17, 2024 | |
| Reset | Dec 3, 2024 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Oct 17, 2024 | Dec 3, 2024 |
| ID | Term |
|---|---|
| D011020 | Pneumonia, Pneumocystis |
| D055744 | Invasive Pulmonary Aspergillosis |
| ID | Term |
|---|---|
| D008172 | Lung Diseases, Fungal |
| D009181 | Mycoses |
| D001423 | Bacterial Infections and Mycoses |
| D007239 | Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
|
30-day and 100-day mortality (including all-cause mortality and attributable mortality of pulmonary complications) in patients undergoing BAL
| 30-day and 100-day after BAL |
| D016720 |
| Pneumocystis Infections |
| D012141 | Respiratory Tract Infections |
| D011014 | Pneumonia |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D055732 | Pulmonary Aspergillosis |
| D001228 | Aspergillosis |
| D000072742 | Invasive Fungal Infections |